Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features

Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features

Acquired myasthenia gravis (MG) is a prototype autoimmune disease of the neuromuscular junction, caused in most patients by autoantibodies to the muscle nicotinic acetylcholine receptor (AChR). There seem to be ethnic and regional differences in the frequency and clinical features of MG seronegative...

Descripció completa

Dades bibliogràfiques
Autors principals:	Park, K, Waters, P, Woodhall, M, Lang, B, Smith, T, Sung, J, Kim, K, Lim, Y, Kim, J, Kim, B, Park, J, Lim, J, Kim, D, Kwon, O, Sohn, E, Bae, J, Yoon, B, Kim, N, Ahn, S, Oh, J, Park, H, Shin, K, Hong, Y
Altres autors:	Mei, L
Format:	Journal article
Idioma:	English
Publicat:	Public Library of Science 2018

Ítems similars

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
per: Lee, J, et al.
Publicat: (2006)

Myasthenia gravis seronegative for acetylcholine receptor antibodies.
per: Vincent, A, et al.
Publicat: (2008)

Seronegative myasthenia gravis.
per: Vincent, A, et al.
Publicat: (2004)

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
per: Leite, M, et al.
Publicat: (2008)

Antibodies to clustered acetylcholine receptor and thymic changes in seronegative myasthenia gravis
per: Leite, M, et al.
Publicat: (2007)

Antibodies to AChRs in seronegative myasthenia gravis
per: Leite, M, et al.
Publicat: (2006)

Diagnostic use of autoantibodies in myasthenia gravis.
per: Leite, M, et al.
Publicat: (2010)

SERONEGATIVE MYASTHENIA GRAVIS-CLINICAL/SEROLOGICAL ASPECTS
per: Huda, S, et al.
Publicat: (2014)

Clinical value of cell-based assays in the characterisation of seronegative myasthenia gravis
per: Damato, V, et al.
Publicat: (2022)

Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets.
per: Vincent, A, et al.
Publicat: (2003)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
per: McConville, J, et al.
Publicat: (2004)

Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation.
per: Spreadbury, I, et al.
Publicat: (2005)

Clinical and functional characteristics of seronegative and musk myasthenia gravis
per: Huda, S
Publicat: (2017)

Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.
per: Nemoto, Y, et al.
Publicat: (2005)

Acetylcholine receptor antibody in Thai generalized myasthenia gravis patients.
per: Jitpimolmard, S, et al.
Publicat: (2006)

Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
per: Mygland, A, et al.
Publicat: (2000)

Detection of musk antibodies in seronegative myasthenia gravis using human musk as antigen
per: McConville, J, et al.
Publicat: (2002)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
per: Newsom-Davis, J, et al.
Publicat: (2001)

IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
per: Blaes, F, et al.
Publicat: (2000)

Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis.
per: Oskoui, M, et al.
Publicat: (2008)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
per: Jacob, S, et al.
Publicat: (2008)

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
per: Yeh, J, et al.
Publicat: (2004)

Collagen Q - A potential target for autoantibodies in myasthenia gravis.
per: Zoltowska Katarzyna, M, et al.
Publicat: (2015)

Myasthenia gravis.
per: Vincent, A, et al.
Publicat: (2001)

Autoantibodies in different forms of myasthenia gravis and in the Lambert-Eaton syndrome.
per: Vincent, A
Publicat: (2008)

Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis.
per: Jacob, S, et al.
Publicat: (2012)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
per: Shiraishi, H, et al.
Publicat: (2005)

The management of myasthenia gravis
per: Hilton-Jones, D, et al.
Publicat: (2005)

Autoimmune myasthenia gravis.
per: Jayawant, S, et al.
Publicat: (2013)

Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library.
per: Farrar, J, et al.
Publicat: (1997)

Myasthenia gravis.
per: Vincent, A, et al.
Publicat: (2002)

Myasthenia gravis
per: Vincent, A
Publicat: (2007)

Myasthenia gravis.
per: Vincent, A, et al.
Publicat: (2004)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
per: Deymeer, F, et al.
Publicat: (2007)

Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
per: Losen, M, et al.
Publicat: (2005)

A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
per: Palace, J, et al.
Publicat: (1998)

Characterization of pathogenic monoclonal autoantibodies derived from muscle-specific kinase myasthenia gravis patients
per: Takata, K, et al.
Publicat: (2019)

Predictive Value of Anti-Ro Antibody Positivity for Anti-AQP4 Autoantibody Test Results in Patients with Demyelinating Disease of Central Nervous System
per: Kim, J, et al.
Publicat: (2012)

The search for new antigenic targets in myasthenia gravis.
per: Cossins, J, et al.
Publicat: (2012)

Fetal acetylcholine receptor inactivation syndrome and maternal myasthenia gravis: A case report
per: D'Amico, A, et al.
Publicat: (2012)